Gaje, Melargin C.

HRN: 27-67-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
CEFUROXIME 1.5GM (VIAL)
09/18/2025
09/18/2025
IV
1.5 Grams
PT
Prophylaxis
Remove - Pending Acceptance
09/19/2025
CEFUROXIME 500MG (TAB)
09/19/2025
09/25/2025
PO
500mg
BID
SP CS
Remove - Pending Acceptance
09/19/2025
MUPIROCIN 2%, 15G (TUBE)
09/19/2025
09/25/2025
TOPICAL
1ml
BID
SP CS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: